ResMed news
ΓResMed
29.04.22
ResMed
The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is May 10, 2022. The annual dividend yield may reach 0.66%.
The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is May 10, 2022. The annual dividend yield may reach 0.66%.
Source: 
investor.resmed.com
investor.resmed.com
0
0
29.04.22
ResMed
ResMed's GAAP net income for 9 months of fiscal 2022 was $584.4 million, up 2.1 times from $279.4 million in the prior year. Revenues increased 14.8% to $2.663 billion from $2.32 billion a year earlier.
ResMed's GAAP net income for 9 months of fiscal 2022 was $584.4 million, up 2.1 times from $279.4 million in the prior year. Revenues increased 14.8% to $2.663 billion from $2.32 billion a year earlier.
Source: investor.resmed.com
investor.resmed.com
0
0
28.01.22
ResMed
ResMed's GAAP net income for 6 months of fiscal 2022 was $405.364 million, up 13.3% from $357.886 million in the prior year. Revenue increased 15.9% to $1.799 billion from $1.552 billion a year earlier.
ResMed's GAAP net income for 6 months of fiscal 2022 was $405.364 million, up 13.3% from $357.886 million in the prior year. Revenue increased 15.9% to $1.799 billion from $1.552 billion a year earlier.
Source: investor.resmed.com
investor.resmed.com
0
0
29.10.21
ResMed
ResMed's GAAP net income for 3M 2022 fiscal year was $203.613 million, up 14.2% from $178.372 million in the prior year. Revenue increased 20.2% to $904.015 million from $751.944 million a year earlier.
ResMed's GAAP net income for 3M 2022 fiscal year was $203.613 million, up 14.2% from $178.372 million in the prior year. Revenue increased 20.2% to $904.015 million from $751.944 million a year earlier.
Source: investor.resmed.com
investor.resmed.com
0
0
28.10.21
ResMed
The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is November 9, 2021. The annual dividend yield may reach 0.7%.
The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is November 9, 2021. The annual dividend yield may reach 0.7%.
Source: investor.resmed.com
investor.resmed.com
0
0
06.08.21
ResMed
ResMed's GAAP net income for fiscal 2021 was $474.505 million, down 23.7% from $621.674 million in the prior year. Revenue declined 2.5 times to $1.197 billion from $2.957 billion a year earlier.
ResMed's GAAP net income for fiscal 2021 was $474.505 million, down 23.7% from $621.674 million in the prior year. Revenue declined 2.5 times to $1.197 billion from $2.957 billion a year earlier.
Source: investor.resmed.com
investor.resmed.com
0
0
05.08.21
ResMed
The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is August 17, 2021. The annual dividend yield may reach 0.72%.
The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is August 17, 2021. The annual dividend yield may reach 0.72%.
Source: 
investors.resmed.com
investors.resmed.com
0
0
30.04.21
ResMed
ResMed's GAAP net income for nine months of fiscal 2021 was $279.405 million, down 37% from $443.839 million in the prior year. Revenue increased 6.1% to $2.321 billion compared to $2.187 billion a year earlier.
ResMed's GAAP net income for nine months of fiscal 2021 was $279.405 million, down 37% from $443.839 million in the prior year. Revenue increased 6.1% to $2.321 billion compared to $2.187 billion a year earlier.
Source: investors.resmed.com
investors.resmed.com
0
0
29.04.21
ResMed
The ResMed Board of Directors announced a quarterly dividend of $0.39 per share. The last day to buy securities to receive the dividend is May 11, 2021. The annual dividend yield may reach 0.8%.
The ResMed Board of Directors announced a quarterly dividend of $0.39 per share. The last day to buy securities to receive the dividend is May 11, 2021. The annual dividend yield may reach 0.8%.
Source: investors.resmed.com
investors.resmed.com
0
0
29.01.21
ResMed
ResMed's GAAP net income for 6 months of fiscal 2021 was $357.9 million, up 27.5% from $280.7 million in the prior year. Revenue increased 9.5% to $1.552 billion compared to $1.417 billion a year earlier.
ResMed's GAAP net income for 6 months of fiscal 2021 was $357.9 million, up 27.5% from $280.7 million in the prior year. Revenue increased 9.5% to $1.552 billion compared to $1.417 billion a year earlier.
Source: investor.resmed.com
investor.resmed.com
0
0
English (US) 